Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes

• Status: Not yet recruiting
• Trial end date: 2022-03-01
• Target enrollment: 0
• Participant gender: All

Summary

This study aims to compare the effectiveness of Dextenza vs standard of care prednisolone taper after cataract surgery in diabetic patients with regards to controlling post-op inflammation at post-op days 7, 14, and 30.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Baylor Research Institute
• Treatments: Methylprednisolone; Methylprednisolone Acetate; Methylprednisolone Hemisuccinate; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate

Criteria

Inclusion Criteria:

• Patients with diagnosed diabetes

• Patients must be undergoing cataract surgery in each eye

• Patients must have no worse than moderate nonproliferative diabetic retinopathy

Exclusion Criteria:

• Patients must not have any history of documented macular edema on OCT

• Patients must not have any macular edema on pre-op OCT

• Patients must not have any history of uveitis

• Patients must not have severe nonproliferative or proliferative diabetic retinopathy

• Patients with operative complications will be excluded from this study

• Patients with any active corneal disease, infectious or rheumatologic, will be excluded

• Patients must not be pregnant